To describe what is idiopathic pulmonary fibrosis. Please see disclaimer on my website. www.academyofprofessionals.com
Views: 40156 hammadshams
Idiopathic Pulmonary Fibrosis is a progressive scarring lung condition. This simple animation explains how it occurs, the key symptoms, and how best to manage the condition. We hope this video will be useful to you and those around you. UPDATE: Now including subtitles in English, Arabic, Chinese, French, Japanese, Russian and Spanish. Thank you to Trommons Translators and The Rosetta Foundation for providing the translations. HealthSketch is a project set up by a group of UK junior doctors to convey health information in visually engaging ways, empowering us all to lead healthier lives. For more information, please visit: Website: http://www.health-sketch.com/ Twitter: https://twitter.com/health_sketch Facebook: http://facebook.com/healthsketch Whiteboard Animation by Russ Law: [email protected] All content, including graphics, audio, text, and links, is for information and education purposes only. This video should not be considered a substitute for professional medical care, so if you have further questions or concerns, please consult a medical professional. This video was supported by: Chest Heart & Stroke Scotland http://www.chss.org.uk
Views: 10812 HealthSketch
What is CRYPTOGENIC DISEASE? What does CRYPTOGENIC DISEASE mean? CRYPTOGENIC DISEASE meaning - CRYPTOGENIC DISEASE definition - CRYPTOGENIC DISEASE explanation. Source: Wikipedia.org article, adapted under https://creativecommons.org/licenses/by-sa/3.0/ license. SUBSCRIBE to our Google Earth flights channel - https://www.youtube.com/channel/UC6UuCPh7GrXznZi0Hz2YQnQ A cryptogenic disease is a disease of which the cause is unknown. It may be used in a particular case, when the nature of the patient's condition is known but the cause has not been found (e.g. cryptogenic stroke). The word cryptogenic also appears in the names of some disease entities, when the situation is sufficiently common to be considered a diagnosis in its own right (e.g. cryptogenic fibrosing alveolitis). Cryptogenic, idiopathic and primary may all be used in both these senses, but cryptogenic is more likely to be used where there is presumed to be a simple cause but this happens to have eluded discovery. Cryptogenic is used in this technical sense in the description of epilepsy syndromes (although the distinction has now been officially abandoned). In practice, the term cryptogenic is largely restricted to certain specific conditions. These include: diseases of the lung: cryptogenic fibrosing alveolitis, cryptogenic organizing pneumonia. diseases of the liver: cryptogenic cirrhosis, cryptogenic hepatitis. diseases of the brain: cryptogenic stroke, cryptogenic epilepsy.
Views: 385 The Audiopedia
A short video about features of interstitial lung Disease
Views: 97549 hammadshams
This video provides radiological classification of causes of lung fibrosis. Lung fibrosis is caused by a number of conditions. Diagnosing causes of lung fibrosis as to institute proper treatment and in case of any environmental/occupational factors causing the disease, their further exposure can be avoided. Radiologically the site of fibrosis gives important clue towards the cause of fibrosis which in a combination with history and examination can give important insight into the causative factor. ....................................................................................... Please Visit & Subscribe Our Channel for Latest Videos: https://www.youtube.com/lastsecondmedicine Visit us on Facebook: https://www.facebook.com/lastsecondmedicine Follow us on Twitter: https://twitter.com/Last_Second_Med Support us on Patreon: https://www.patreon.com/lastsecondmedicine Please Leave you valued suggestion in Comments.
Views: 802 Last Second Medicine
This video is a community project by Rainbow Across Borders. Mr Ijas Ali passed away in 2017 shortly after this video was filmed. He has made a significant impact in moving IPF forward in Singapore. We are grateful and honoured to have met Mr Ijas Ali in this journey to improve care for IPF patients. - About IPF - Pulmonary fibrosis (PF), the most common type of interstitial lung disease, is characterised by thick and stiff tissue that turns into scar tissue over time. Because of the increasing presence of scar tissue in the lungs, the organ is not able to properly transport oxygen into the bloodstream. When the blood does not get enough oxygen, symptoms result including shortness of breath; persistent, dry and hacking cough; fatigue; unexplained weight loss; aching muscles and joints; and clubbing of the fingertips. While the majority of pulmonary fibrosis cases are classified as IDIOPATHIC, meaning the cause is not fully understood, there are numerous reasons known that contribute to the disease development. These include: occupational and environmental exposure to pollutants, specific medication or drugs, radiation therapy, some connective tissue diseases and interstitial lung disease. Treatments for pulmonary fibrosis include medicines, oxygen therapy, pulmonary rehabilitation, or a lung transplant. Pulmonary fibrosis is a progressive and life-threatening disease with a poor prognosis. Patients with pulmonary fibrosis frequently need to be hospitalised with respiratory problems and often experience subacute deterioration before passing on. Ischemic heart disease, heart failure, bronchogenic carcinoma, infection and pulmonary embolism are also common causes of mortality among these patients.
Views: 3373 Rainbow Across Borders
Subscribe to the drbeen Channel HERE: http://bit.ly/2GBhiS0 For more content from drbeen, click HERE: http://bit.ly/2GB41bU Watch drbeen videos HERE: http://bit.ly/2GB41bU Like drbeen on Facebook HERE: http://bit.ly/2GSSTGS Follow drbeen on Twitter HERE: http://bit.ly/2XeSVhV Follow drbeen on Instagram HERE: http://bit.ly/2ST2Zih Get new medical lectures across your devices. Stream anywhere, anytime. Try it for free! http://bit.ly/2QsIwQ5 This video is part of the series of videos discussing restrictive lung diseases. We will discuss hypersensitivity pneumonitis in this talk. Definition. Alveolitis due to inhaled external allergens. Involves smaller airways and the respiratory zones instead of the large airways. The difference in this disease from asthma. This is a mixture of type III and type IV allergies. Pathophysiology of the hypersensitivity pneumonitis. Macrophages. Allergen presentation to T and B cells in the lymph nodes. Interleukins released. Phases of hypersensitivity pneumonitis. Acute and Chronic. Role of neutrophils and T cells in the acute phase. Granuloma formation in the chronic phase. Why hypersensitivity pneumonitis is also classified as a granulomatous disease. IL4, IL5, IL12, C5a. Scarring of the respiratory zones. Fever, dyspnea, cough, lethargy, malaise, restrictive lung disease. FEV1 reduced. FEV1/FVC increased due to increased elasticity and rapid expulsion. Monday morning blues experienced by the patients. Industries/tasks that cause this disease Fungi and bacteria from farming work - Farmer's Lung. Micropolyspora fanny and bagassosis. Thermophilic actinomycetes.Cheese workers - moldy cheese. Penicillium Casey. Miller's lungs. Dusty grain. Animal products, pigeon breeder's lungs. Pigeon droppings have pigeon serum proteins. Other chemical industry workers.
Views: 12976 Drbeen Medical Lectures
Professor Vincent Cottin discusses why idiopathic pulmonary fibrosis (IPF) is often misdiagnosed
What is the Life Expectancy and Outlook for Idiopathic Pulmonary Fibrosis. Idiopathic pneumonic fibrosis (IPF) is a ceaseless lung sickness that includes the development of scar tissue somewhere inside the lungs, between the air sacs. This harmed lung tissue turns out to be hardened and thick, making it troublesome for your lungs to work proficiently. The subsequent trouble in breathing prompts bring down levels of oxygen in the circulation system. As a rule, the life expenctancy with IPF is around three to five years. What's in store. At the point when looked with another analysis, it's normal to have heaps of inquiries. You're most likely pondering what you can expect regarding your anticipation and future. Standpoint. Since IPF is an incessant, dynamic sickness, you'll have it for whatever remains of your life. All things considered, the anticipation for individuals with IPF can change incredibly. While a few people may wind up wiped out rapidly, others may advance all the more gradually finished the course of quite a long while. By and large, there are a few side effects that are regular among individuals with IPF. Shortness of Breath. With IPF, your lungs aren't filling in as they should, and your body reacts to the absence of oxygen in your circulatory system by influencing you to feel like you have to inhale more. This triggers a shortness of breath, particularly amid times of expanded action. Over the long haul, you'll most likely begin to feel this same windedness notwithstanding amid times of rest. Weariness. Low levels of oxygen in the blood can tire you out, abandoning you feeling depleted and for the most part unwell. This sentiment tiredness might be exacerbated on the off chance that you look to keep away from physical movement since you would prefer not to feel shy of breath. Hacking. A dry, hacking hack is a continuous objection among IPF patients. You may encounter "hacking fits," where you can't control your hack for a few minutes. This can be extremely tiring, and can influence you to feel like you can't get a breath by any stretch of the imagination. You might be more inclined to hacking fits when: *you're practicing or playing out any kind of movement that abandons you shy of breath. *you're feeling enthusiastic, snickering, crying, or talking. *you're in conditions with higher temperature or mugginess. *you're in closeness or come into contact with toxins or different triggers like clean, smoke, or solid scents. Aspiratory Hypertension. Aspiratory hypertension is hypertension in the lungs. This can happen in light of the diminished oxygen level in your blood. Since hypertension influences your heart to work harder than typical, it can prompt heart disappointment if oxygen levels don't make strides. Weight reduction. It can be difficult to eat well with IPF. Biting and gulping nourishment can make breathing more troublesome, and eating complete suppers can influence your stomach to feel awkwardly full and increment the workload of your lungs. Along these lines, it's vital to eat supplement thick nourishment as opposed to garbage sustenance. You may think that its accommodating to eat littler measures of nourishment more every now and again instead of three, bigger suppers also. Propelling Complications. As your condition propels, you'll be at expanded hazard forever undermining entanglements, including: *heart assault and stroke. *pulmonary embolism (blood clusters in the lungs). *respiratory disappointment. *heart disappointment. *serious contaminations in the lungs. Future: Future can likewise fluctuate in patients with IPF. Your own future is probably going to be impacted by the movement of your infection and the power of your manifestations. You might have the capacity to build the three to five year term time, and enhance the nature of your life, by conversing with your specialist about approaches to deal with your manifestations and your ailment movement. There's no cure for IPF, yet inquire about through the National Heart, Lung, and Blood Institute is attempting to bring issues to light of the sickness, fund-raise for research, and lead clinical trials to scan for an existence sparing cure. All Photos Licensed Under CC Source : www.pexels.com www.pixabay.com www.commons.wikimedia.org
Views: 4726 Natural Health Benefits
Read the full paper here: http://thorax.bmj.com/content/70/12/1138.full Huang LS, Berdyshev EV, Tran JT et al. Thorax doi:10.1136/thoraxjnl-2014-206684 Introduction Idiopathic pulmonary fibrosis is characterised by accumulation of fibroblasts and myofibroblasts and deposition of extracellular matrix proteins. Sphingosine-1-phosphate signalling plays a critical role in pulmonary fibrosis. Methods S1P lyase expression in peripheral blood mononuclear cells was correlated with pulmonary functions and overall survival; used a murine model to check the role of S1PL on the fibrogenesis and a cell culture system to study the effect of S1PL expression on transforming growth factor-β- and S1P-induced fibroblast differentiation. Results S1PL expression was upregulated in fibrotic lung tissues and primary lung fibroblasts isolated from patients with IPF and bleomycin-challenged mice. TGF-β increased the expression of S1PL in human lung fibroblasts via activation and binding of Smad3 transcription factor to Sgpl1 promoter. Overexpression of S1PL attenuated TGF-β-induced and S1P-induced differentiation of human lung fibroblasts through regulation of the expression of LC3 and beclin 1. Knockdown of S1PL in mice augmented bleomycin-induced pulmonary fibrosis, and patients with IPF reduced Sgpl1 mRNA expression in PBMCs exhibited higher severity of fibrosis and lower survival rate. Conclusion These studies suggest that S1PL is a novel endogenous suppressor of pulmonary fibrosis in human IPF and animal models.
Views: 364 Thorax
There are limited treatment options available for patients with IPF including long-term oxygen therapy and pulmonary rehabilitation. Learn more about IPF here: http://www.soundsofipf.com
Views: 9288 Boehringer Ingelheim
Learn about pulmonary fibrosis, a set of diseases that cause progressive scarring inside the lungs. Over time the lungs are slowly replaced with scar tissue, which causes airways to restrict airflow, making it difficult to breath and to get enough oxygen. Doctors, patients and researchers are hoping clinical trials will lead to a drug that prevents lung function from worsening ultimately allowing patients to live longer.
Views: 52163 Health Science Channel
Usual interstitial pneumonia is a form of lung disease characterized by progressive scarring of both lungs. The scarring involves the supporting framework of the lung. UIP is thus classified as a form of interstitial lung disease. The term "usual" refers to the fact that UIP is the most common form of interstitial fibrosis. "Pneumonia" indicates "lung abnormality", which includes fibrosis and inflammation. A term previously used for UIP in the British literature is cryptogenic fibrosing alveolitis, a term that has fallen out of favor since the basic underlying pathology is now thought to be fibrosis, not inflammation. This video is targeted to blind users. Attribution: Article text available under CC-BY-SA Creative Commons image source in video
Views: 2258 Audiopedia
Pulmonary fibrosis is a vague terminology where a group of diseases which causes pulmonary fibrosis have been terminated as pulmonary fibrosis. There are 6 to 7 variants in pulmonary fibrosis, overall to the general public, pulmonary fibrosis means fibrosing of the lung, which is normally an elastic structure. But gets fibrosed because of many known and unknown causes. Sometimes we don’t even know what causes the fibrosis and the incidence of this is increasing and here the disease affected, patients will not be able to breathe, they will have executional breathlessness and symptoms which ultimately affects the oxygenation of the lung. So he has to suffer and become more debilitated and respiratory crippled.
What is IDIOPATHY? What does IDIOPATHY mean? IDIOPATHY meaning, definition & explanation. An idiopathy is any disease with unknown pathogenesis or apparently spontaneous origin. From Greek ????? idios "one's own" and ????? pathos "suffering", idiopathy means approximately "a disease of its own kind". For some medical conditions, one or more causes are somewhat understood, but in a certain percentage of people with the condition, the cause may not be readily apparent or characterized. In these cases, the origin of the condition is said to be idiopathic. With some other medical conditions, the root cause for a large percentage of all cases have not been established—for example, focal segmental glomerulosclerosis or ankylosing spondylitis; the majority of these cases are deemed idiopathic. With other conditions, idiopathic cases account for only a small percentage (for example, pulmonary fibrosis). Advances in medical science improve etiology (the study of causes of diseases) and nosology (the classification of diseases); thus, regarding any particular condition or disease, as more root causes are discovered, and as events that seemed spontaneous have their origins revealed, the percentage of cases designated as idiopathic decreases. The word essential is sometimes synonymous with idiopathic (as in essential proteinuria or essential thrombocythemia), and the same is true of primary (as in primary biliary cirrhosis or primary amenorrhea), with the latter term being used in such cases to contrast with secondary in the sense of "secondary to some other condition." Another, less common synonym is agnogenic (agno-, "unknown" + -gen, "cause" + -ic). The word cryptogenic (crypto-, "hidden" + -gen, "cause" + -ic) has a sense that is synonymous with idiopathic and a sense that is contradistinguished from it. Some congenital conditions are idiopathic, and sometimes the word congenital is used synonymously with idiopathic; but careful usage prefers to reserve the word congenital for conditions to which the literal sense of the word applies (that is, those whose pathophysiology has existed since the neonatal period).
Views: 185 The Audiopedia
Professor Ulrich Costabel discusses the signs and symptoms of idiopathic pulmonary fibrosis (IPF). IPF is a disease which starts with cough and increased dyspnea on exertion. The clinical signs of IPF are bibasilar inspiratory ‘Velcro crackles’, distinctive, Velcro-like crackling sounds that can be detected through a stethoscope. Healthcare professionals outside the US, UK, and Canada, listen to the example patient auscultations of IPF and other pulmonary diseases, visit http://www.inipf.com/diagnosis-of-ipf/Listen-to-IPF.html
Views: 15585 Boehringer Ingelheim Idiopathic Pulmonary Fibrosis
Professor Vincent Cottin discusses the diseases idiopathic pulmonary fibrosis (IPF) is often confused with. IPF is most often confused with NSIP (non-specific interstitial pneumonia) because of similar imaging and clinical features between both diseases. Healthcare professionals outside the US, UK, and Canada, learn more about differential diagnosis of IPF, visit http://www.inipf.com/diagnosis-of-ipf/differential_diagnosis.html
http://BaylorHealth.com/LungTransplant – Howard Huang, M.D., assistant medical director of lung transplantation at Baylor University Medical Center at Dallas, explains treatment for idiopathic pulmonary fibrosis and new medications that are helping reduce symptoms and slow the disease progression. http://BaylorHealth.com/LungTransplant
Views: 6440 Baylor Scott & White Health
http://www.takebackyourhealth.com/ http://www.takebackyourhealth.com/cardio-zyme.html http://www.takebackyourhealth.com/super-digesta-zyme.html Patients of pulmonary fibrosis lung disease are explained by their doctors that there is no known pulmonary fibrosis treatment and they may have up to five years to live. Happily for them, there is an alternative therapy with systemic enzymes that help treat fibrosis of lungs. What is Pulmonary Fibrosis Definition? Pulmonary or lung fibrosis happens when excess fibrous connective tissue, called fibrosis (scarring), develops throughout the lungs. This scarring is actually a natural process that involves the replacement of the normal tissue loss with fibrous tissue when there is a damage, infection or injury in the lung. This disease is most often found in people with age between 50 and 70 years old. Causes There are many fibrosis of lungs causes. They can be resulted as the secondary effects of viral infections, autoimmune disorders, microscopic injuries to lung, rheumatoid arthritis, lupus, SLE, scleroderma, exposure to radiation/asbestos/silica/certain gases, smoking and certain medications. This condition is known as Interstitial Lung Diseases. However, on some other cases, the causes can't be identified. This condition is called Idiopathic Pulmonary Fibrosis or IPF. http://www.takebackyourhealth.com/blog/ http://www.takebackyourhealth.com/articles.html
Views: 13560 enzymestherapy
A pulmonary pathologist describes a recently identified form of interstitial fibrosis (IF), smoking-related IF, and explains the often-confusing term "respiratory bronchiolitis."
Views: 853 Cleveland Clinic
Nancy introduces herself and discusses the symptoms she experienced before being diagnosed with pulmonary fibrosis. For more information visit www.EmpowHER.com.
Views: 7858 EmpowHER
This video is a recording of an interview with Dr. Gerard Cox shown to high school students from Hamilton, Ontario at a dissemination event at McMaster University on December 2, 2013.
Views: 5714 Demystifying Medicine
Tony Gowland, an ambassador for Action for Pulmonary Fibrosis, talks about IPF and his experiences with it and the charity. http://www.actionpulmonaryfibrosis.org/2016/id-rather-have-cancer Read Tony's first blog "I'd rather have cancer" on our website.
Views: 1880 Action for Pulmonary Fibrosis
Irene Byrne, Physiotherapist, talk for IPF patients. Filmed at the Irish Lung Fibrosis Association's information day. Video is copyright © 2013, Irish Lung Fibrosis Association. Any unauthorised copying, duplication or distribution is prohibited.
Views: 1051 ILFA Ireland
More than 40,000 people die each year from idiopathic pulmonary fibrosis, a condition with no effective treatment. Now, researchers at the University of Michigan have discovered a therapeutic target in mice that could lead to treatment for patients.
Views: 3027 Michigan Medicine
Professor Jürgen Behr describes what Idiopathic Pulmonary Fibrosis (IPF) is, and provides insights into the ongoing processes in the lungs of patients with IPF. Patients outside the US with IPF, find information and resources on IPF at http://www.lifewithIPF.com/
Presentation by Roger F. Johnson, MD, FCCP for the 2009 Pulmonary Fibrosis Symposium at St. Mary's Medical Center in Evansville, Indiana. Part 2 of 6.
Views: 1218 pfpartners
Pulmonary fibrosis affects more than 5 million people world-wide, yet it remains a mysterious and incurable disease. A recent discovery could someday change that. Researchers have uncovered a clue as to how this devastating lung disease is formed.
Views: 15114 MediaSourceTV
"OBSERVE What Are The Signs And Symptoms Of Pulmonary Fibrosis? LIST OF RELATED VIDEOS OF What Are The Signs And Symptoms Of Pulmonary Fibrosis? What Are The Signs And Symptoms Of Respiratory Failure? https://www.youtube.com/watch?v=zkL6Ze-QOIM What Are The Signs And Symptoms Of Vitiligo? https://www.youtube.com/watch?v=20WqOfOrO6A What Are The Signs Of A Bad Ball Joint? https://www.youtube.com/watch?v=3ssNiIKY6IE What Are The Signs Of A Bad Catalytic Converter? https://www.youtube.com/watch?v=t33tUhpCnwA What Are The Signs Of A Brain Tumor In A Child? https://www.youtube.com/watch?v=rSLtOhGD5gk What Are The Signs Of A Learning Disability? https://www.youtube.com/watch?v=JvqgbaFCsyE What Are The Signs Of A Pin Stroke? https://www.youtube.com/watch?v=gYrvf2v5fbQ What Are The Signs Of A Psychotic Break? https://www.youtube.com/watch?v=wq7B9-hOWuw What Are The Signs Of A Sprained Finger? https://www.youtube.com/watch?v=2l67Fult7So What Are The Signs Of A Stillborn Baby? https://www.youtube.com/watch?v=-F5s2ygh5K8"
Views: 45 mad Video Marketing
Pulmonary Fibrosis is a disease in which tissue deep in your lungs becomes thick and stiff, or scarred, over time. The formation of scar tissue is called fibrosis. As the lung tissue thickens, your lungs can't properly move oxygen into your bloodstream. As a result, your brain and other organs don't get the oxygen they need. Sometimes doctors can find out what's causing fibrosis. But in most cases, they can't find a cause. They call these cases Idiopathic Pulmonary Ffibrosis, more commonly known as 'IPF'. IPF is a serious disease that usually affects middle-aged and older adults. IPF varies from person to person. In some people, fibrosis happens quickly. In others, the process is much slower. In some people, the disease stays the same for years. IPF has no cure yet. Many people live only about 3 to 5 years after diagnosis. The most common cause of death related to IPF is respiratory failure. Other causes of death include pulmonary hypertension, heart failure, pulmonary embolism, pneumonia, and lung cancer. Research has helped doctors learn more about IPF. As a result, they can more quickly diagnose the disease now than in the past. Also, researchers are studying several medicines that may slow the progress of IPF. These efforts may improve the lifespan and quality of life for people who have the disease. In this programme we hear the expert views of Roland Du Bois, Professor of Respiratory Medicine at Imperial College of London who discusses the challenges faced in managing IPF and his hopes for the newer approaches emerging to manage the disease. We also hear from Joseph McCool who gives a first hand account of living with and managing IPF.
Views: 8181 EdirectTV
http://www.takebackyourhealth.com/ http://www.takebackyourhealth.com/cardio-zyme.html http://www.takebackyourhealth.com/super-digesta-zyme.html Symptoms When you suffer from this disease, some symptoms and signs can appear. They are shortness of breath, chest discomfort, dry coughing, weakness, fatigue, weight loss because of losing appetite. Fibrosis of Lungs Treatments Until today, it is a fact that no such treatments or medications for idiopathic pulmonary fibrosis that can give significant improvement on the patient's condition. The scarring that has been developed is permanent. According to the research, the immune system in our body seems to give significant contribution on this condition. That is the similarity that has been found in many forms of pulmonary fibrosis. Based on this founding, then the medication that has been prescribed to the patients is corticosteroids, such as prednisone. This Non Steroidal Anti Inflammatory Drug is known as immune suppressive agent for slowing down the lung inflammation and scarring. http://www.takebackyourhealth.com/blog/ http://www.takebackyourhealth.com/articles.html
Views: 9405 enzymestherapy
Nancy shares when she was diagnosed with pulmonary fibrosis and how this has changed her life. For more information visit www.EmpowHER.com.
Views: 623 EmpowHER
http://www.CoalitionforPF.org. Watch in High Quality mode. This is the new national PSA by The Coalition for Pulmonary Fibrosis. Directed by David C. Bojorquez of Vision4Media Productions, this :30 spot brings to attention the immediate need to address one of the deadliest and fastest growing diseases in our nation.
Views: 7686 CoalitionForPF
Presentation by Roger F. Johnson, MD, FCCP for the 2009 Pulmonary Fibrosis Symposium at St. Mary's Medical Center in Evansville, Indiana. Part 5 of 6.
Views: 627 pfpartners
Presentation by Roger F. Johnson, MD, FCCP for the 2009 Pulmonary Fibrosis Symposium at St. Mary's Medical Center in Evansville, Indiana. Part 1 of 6.
Views: 2511 pfpartners
Equine multinodular pulmonary fibrosis is a severe form of interstitial fibrosis associated with the equine gammaherpes virus, equine herpesvirus type 5 (EHV-5) The macroscopic images and microscopic slide scan are courtesy of the Joint Pathology Center. For more details about EMPF, please visit: https://www.askjpc.org/vspo/show_page.php?id=856 For many additional interesting cases, please visit the JPC at: https://www.askjpc.org/vspo/search_currVSPO.php
Views: 484 Pathology Dynamics